Lilly wins approval for long-acting Zyprexa
Once-a-month injection of best-selling drug will have patents that could extend until 2018.
Once-a-month injection of best-selling drug will have patents that could extend until 2018.
The Eli Lilly and Co. Foundation has given Indiana University $1 million to start a school of public health at Indiana University-Purdue
University Indianapolis.
The Indianapolis-based drugmaker predicts strong profits through 2011, but its forecast for 2012 suggests bottom-line results
could fall precipitously.
The fund would acquire experimental drugs and use Lilly R&D staff to try to prove their effectiveness, perhaps boosting Lilly’s drug pipeline.
Eli Lilly and Co. said it still expects its earnings per share to grow in the double-digit range through 2011.
Adding the 22-mall portfolio of Baltimore-based Prime Outlets will give Simon a total of 63 outlet malls with more than 25
million square feet of space.
A federal appeals court will decide whether Eli Lilly and Co. must pay $65.2 million in damages, plus royalties, over a drug-patent
claim.
Say goodbye to tournament tennis in Indy. I feel bad for all those who invested their time, effort and money into sustaining the presence
of world-class tennis here.
Cold storage might become a hot business for a building contractor.
The recession decimated Indiana’s auto-parts makers, but many other manufacturers in the state survived. After a year
adrift in the recession, they see signs of land ahead.
Indianapolis-based Eli Lilly and Co. has won a bid to dismiss part of a negligence lawsuit brought by Mississippi that alleges
improper marketing of antipsychotic drug Zyprexa for unapproved uses.
<p><strong>Dr. Denise L. Johnson Miller</strong> has been named director of the St. Francis Breast Surgery Program, effective
Dec.1. Miller comes from Stanford University Medical Center in California, where she directed cancer outreach and melanoma
surgery programs.<br /><br /><strong>Jeff Smulyan</strong>, CEO of Emmis Communications Corp., has been
named co-chairman of Hoosiers Work for Health, an industry-funded group promoting awareness of social and
economic impacts of the health care industry. Smulyan replaces former Indianapolis mayor <strong>Bart Peterson</strong>,
who took a job as a senior vice president at Indianapolis-based Eli Lilly and Co. The group’s other co-chairman is <strong>Jim
Morris</strong>, president of Pacers Sports and Entertainment.</p><p><strong>Dr. Anh-Danh Phan</strong>
has joined the Eugene and Marilyn Glick Eye Institute at Indiana University School of Medicine’s Department
of Ophthalmology as a visiting assistant clinical professor of ophthalmology. Phan received her medical
degree from Howard University College of Medicine in Washington, D.C.</p>
Jubilant Organosys Ltd. and Indianapolis-based Eli Lilly and Co. extended their collaboration, which began in 2005, by five
years.
FDA action should boost sales of the Eli Lilly and Co. drug, which were already on pace to top $3 billion this year.
The Indianapolis Tennis Championships—formerly known as RCA Championships—appear to be dead, with the ATP Tour
dates being shipped off to Atlanta for 2010 and beyond.
Indiana ranked No. 35—unchanged from last year—on UnitedHealth Foundation’s annual state-by-state ranking of overall public health. While Indiana ranks higher than it did three years ago, the state actually fell five places since UnitedHealth started compiling the ranking in 1990. Since then, obesity in Indiana has surged 130 percent while smoking rates have been stuck for a decade at 26 percent. UnitedHealth’s report says Indiana has good rates of health insurance coverage and does a good job of limiting infectious diseases. But the state suffers from poor air quality and very low public-health funding. The UnitedHealth Foundation is an arm of Minnesota-based health insurer UnitedHealth Group.
Researchers at Purdue University have shown how an experimental drug might restore the function of nerves damaged in spinal-cord injuries and could also treat multiple sclerosis. The experimental compound, 4-aminopyridine-3-methyl hydroxide, has been shown to restore function to damaged axons—slender fibers that extend from nerve cells and transmit electrical impulses in the spinal cord. The researchers’ findings, based on experiments with guinea pig spinal-cord tissue, appeared online Nov. 18 in the Journal of Neurophysiology.
Dr. John Hayes, vice president of Eli Lilly and Co.’s research laboratories and the company’s neuroscience branding leader, will deliver a keynote speech on the possibilities for neuroscience development in Indiana as part of the Neuroscience Summit organization by the Indiana Health Industry Forum. The summit will occur Dec. 4 at University Place Conference Center at IUPUI.
The merged operations of Carmel-based BehaviorCorp and Anderson-based Center for Mental Health will adopt the name Aspire Indiana Behavioral Health System on Jan. 1. The new organization has more than 400 mental health professionals and supporting staff members. Aspire Indiana will serve primarily patients in Madison, Hamilton, Boone and northern Marion counties.
The top scientist at Eli Lilly and Co. will have to trust a company outsider to see if his aggressive transformation of
Lilly’s research and development arm pays off.
Fortune magazine ranked the drug company among the best in the world for managing talent.
California-based Vivus claims its drug acts in 30 minutes, compared with about 2 hours for Lilly’s Cialis.